CTRI/2020/11/029406进行中（未招募）未知
A randomized, double blind, cross over, single center study to evaluate the oral sensory attributes of placebo tablet coatings
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Healthy adult volunteer between 18 and 75 years of age at the time of enrolment who the Investigator believes that he/she can and will comply with the requirements of the protocol (e.g. study assessment completion).
- •2.Female of childbearing potential must have a negative pregnancy test and be non-lactating.
- •3.Subject with no systemic or local conditions or on any medications that might compromise the taste or smell
- •4.Subject who has never smoked, or who has smoked less than 100 cigarettes in his/her lifetime
- •5.Subject signs and dates the written informed consent
- •6.Agree to comply with the study procedures and requirements
排除标准
- •1.Female patients who are pregnant or a nursing mother
- •2.Subject with any impairment in taste.
- •3.Subjects who are determined as being the risk group for COVID-19 as per applicable national guidelines.
- •4.Subject who do not agree to comply with the study procedures
- •5.Subject who is allergic to EazyGlideTM or conventional (Opadry) coatings or to the constituents of placebo tablets
研究者
相似试验
已完成
不适用
A bioavailability study of turmeric extracts in healthy human adult subjects under fasting conditionsCTRI/2014/02/004391Exodus Research Acer16
已完成
3 期
To evaluate effect of KSM-66 Ashwagandha® Capsule (300 mg) in Management of Frailty in Older AdultsCTRI/2022/02/040554Ixoreal Biomed50
进行中（未招募）
1 期
A double-blind, randomized, cross-over, multi-center efficacy and safety study of ibuprofen plus hyoscine butylbromide for pain management due to primary dysmenorrheaEUCTR2022-000843-57-BGRONTIS HELLAS S.A.54
进行中（未招募）
不适用
A Single Center, Double Blind, Randomized Crossover Study Evaluating the Bioequivalence of VIAject®7 compared to VIAject™25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects with Type 1 Diabetes MellitusMedDRA version: 9.1Level: LLTClassification code 10045238Term: Type I diabetes mellitus without mention of complicationType 1 Diabetes MellitusEUCTR2009-012082-54-DEBIODEL inc.
进行中（未招募）
1 期
A clinical trial testing usual dose and double dose oseltamivir (the medicine) in which neither the doctor or patient know what dose of medicine is given for treatment of influenza (the flu), in patients with a weakened immune (protective) system.EUCTR2006-002468-24-BGF.Hoffmann-La Roche Ltd.228